Analysis: Wanbury Limited

NSE:WANBURY Pharma - API Market cap: ₹859 cr

Research report

companyname: Wanbury Limited ticker: WANBURY sector: Pharmaceuticals Wanbury Limited (CIN: L51900MH1988PLC048455) is, in the words of its own filing, "engaged into pharmaceutical." That single line is the most specific description of the business the company gives in the documents. Everything else flows from it: a pharma manufacturer with two plants, a 30-year operating history, and a small group of foreign subsidiaries tucked underneath. The business sits in one reportable segment. The compan...

Read the full report →
RS rating: 7 Stage: Stage 4

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Wanbury Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.